123,95 €
123,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
62 °P sammeln
123,95 €
123,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
62 °P sammeln
Als Download kaufen
123,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
62 °P sammeln
Jetzt verschenken
123,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
62 °P sammeln
  • Format: PDF

Risk analytics is developing rapidly, and analysts in the field need material that is theoretically sound as well as practical and straightforward. A one-stop resource for quantitative risk analysis, this book dispenses concentrates on how powerful techniques and methods can be used correctly within a spreadsheet-based environment

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 17.14MB
Produktbeschreibung
Risk analytics is developing rapidly, and analysts in the field need material that is theoretically sound as well as practical and straightforward. A one-stop resource for quantitative risk analysis, this book dispenses concentrates on how powerful techniques and methods can be used correctly within a spreadsheet-based environment


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Dale E. Lehman, PhD, is Professor of Business Administration and Director of the EMBA in Business Analytics at Loras College. He has taught at numerous universities in North America, Europe, and Asia. He has also published extensively in the areas of microeconomics, with applications in the telecommunications, health care, and natural resource industries. He has authored three previous books in these areas.

Huybert Groenendaal, PhD, is Managing Director at EpiX Analytics. He has extensive experience in using risk modeling to support decision making in fields that include business development, financial valuation, and R&D portfolio evaluation within the pharmaceutical and medical device industries, as well as health and epidemiology, energy, manufacturing and private equity. He regularly teaches risk analysis training classes.